Marinus Pharmaceuticals Inc. (MRNS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Marinus Pharmaceuticals I...

    NASDAQ: MRNS · Real-Time Price · USD
    0.55
    0.00 (0.00%)
    At close: Feb 10, 2025, 3:59 PM

    Marinus Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 120.57M 240.55M 122.93M
    Short-Term Investments
    		 29.72M n/a n/a
    Long-Term Investments
    		 n/a n/a n/a
    Other Long-Term Assets
    		 819K 14.73M 11.41M
    Receivables
    		 3.8M 6.35M 3.19M
    Inventory
    		 2.41M 77K -9.31M
    Other Current Assets
    		 8.75M 5.4M n/a
    Total Current Assets
    		 165.25M 240.55M 122.93M
    Property-Plant & Equipment
    		 4.84M 4.24M 2.5M
    Goodwill & Intangibles
    		 n/a n/a n/a
    Total Long-Term Assets
    		 5.66M 18.97M 13.91M
    Total Assets
    		 170.91M 259.52M 136.84M
    Account Payables
    		 4M 4.46M 3.13M
    Deferred Revenue
    		 n/a n/a 15.65M
    Short-Term Debt
    		 13.76M 1.02M n/a
    Other Current Liabilities
    		 n/a 2.44M 21.23M
    Total Current Liabilities
    		 40.62M 54.87M 40.57M
    Long-Term Debt
    		 95.19M 71.02M 40.81M
    Other Long-Term Liabilities
    		 152K 29.86M n/a
    Total Long-Term Liabilities
    		 113.52M 88.64M 42.79M
    Total Liabilities
    		 154.14M 143.52M 83.35M
    Total Debt
    		 110.36M 72.67M 40.81M
    Book Value
    		 16.77M 116M 53.49M
    Book Value Per Share
    		 0.31 2.97 1.46
    Common Stock
    		 55K 50K 37K
    Retained Earnings
    		 -571.93M -430.52M -410.7M
    Comprehensive Income
    		 -20K n/a n/a
    Shareholders Equity
    		 16.77M 116M 53.49M
    Total Investments
    		 29.72M n/a n/a

    Add to Watchlist